GGrantIndex
Sort

40,608 grants matching prostate cancer

Population Modeling of Bladder Cancer Detection and Control

$653,602
Thomas Trikalinos · Brown University · U01 · FY2023 · CA

Early Detection of Cancer By Affinity Mass Spectrometry

$653,548
Eastern Virginia Medical School · U01 · FY2005 · CA

Improving measurement of cancer registry completeness

$653,500
Timothy L Lash · Emory University · R01 · FY2024 · CA

Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy

$653,256
Nagavarakishore Pillarsetty · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

$653,173
Susan Halabi · Duke University · R01 · FY2020 · CA

PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research

$653,163
Catherine M. Tangen · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA

Evaluation of Transperineal Biopsy under Local Anesthesia, a Novel approach to Decrease Post-Biopsy Infections and Improve Cancer Detection

$652,933
Jim Hu · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Image guided intervention system for pancreatic cystic lesions

$652,932
Nicusor Iftimia · Physical Sciences, Inc · R44 · FY2009 · CA

NSAIDS and Other Medications in Prostate Cancer Etiology

$652,909
Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA

Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients

$652,841
Daniel B Vigneron · University Of California, San Francisco · U01 · FY2021 · CA

HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction

$652,703
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA

GP140/CDCPI IN THE DEVELOPMENT OF PROSTATE CANCER METASTASIS

$652,640
Fred Hutchinson Cancer Research Center · · FY2008 · Department of Defense

Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients

$652,638
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2023 · CA

Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients

$652,638
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2022 · CA

Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology

$652,533
Vadim Backman · Northwestern University · R01 · FY2015 · CA

A RIBOPROTEOMIC PLATFORM TO IDENTIFY NOVEL TARGETS FOR PROSTATE CANCER THERAPY

$652,500
Beth Israel Deaconess Medical Center, Inc. · · FY2014 · Department of Defense

THE SOX9/WNT POSITIVE FEEDBACK LOOP IS A NOVEL THERAPEUTIC TARGET IN ADVANCED PROSTATE CANCER

$652,500
Beth Israel Deaconess Medical Center, Inc. · · FY2015 · Department of Defense

Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer

$652,414
Nupam P Mahajan · Washington University · R01 · FY2024 · CA

Multilevel Resilience Trajectories in the Transition to Cancer Survivorship

$652,405
Crystal L Park · University Of Connecticut Storrs · UH3 · FY2018 · CA

FEASIBILITY STUDY OF A NOVEL DIET-BASED INTERVENTION FOR PROSTATE CANCER

$652,353
University Of California San Diego · · FY2008 · Department of Defense

ATLANTA REGIONAL COMMUNITY CLINICAL ONCOLOGY PROGRAM

$652,311
St. Joseph'S Hospital · U10 · FY2003 · CA

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$652,305
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models

$652,207
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

PROMOTING HEALTH IN PROSTATE &BREAST CANCER

$652,023
Duke University · R01 · FY2001 · CA

Molecular Mechanisms of Castration Resistant Prostate Cancer Recurrence & Therapeutic Strategies

$651,939
Nupam P Mahajan · Washington University · R01 · FY2023 · CA